5-time Grand Slam champion Iga Swiatek has accepted a one-month suspension after testing optimistic for the banned drug trimetazidine, a coronary heart medicine referred to as TMZ, the Worldwide Tennis Integrity Company introduced on Thursday.
Swiatek failed an out-of-competition drug take a look at in August, and the ITIA accepted his rationalization that the consequence was unintentional and brought on by contamination from an unlicensed drug, melatonin, that Swiatek was taking for jet lag and sleep issues.
It was decided that his error charge was “on the low finish of the vary with out vital error or negligence,” IATA stated.
Swiatek is a 23-year-old from Poland who has been ranked No. 1 for the previous two seasons however is now No. 2. He gained the French Open in June for his fifth main and took residence a bronze medal on the Paris Olympics in early August.
Supply hyperlink
